In a recent development that marks a milestone for health-tech startups, Varco Leg Care has successfully raised Rs 2 crore in a bridge funding round. The investment was led by healthcare investment veteran Neeraj Garg, along with contributions from a consortium of other investors.
Varco Leg Care, a company that has made significant strides since its founding in 2022 by entrepreneur Anondeep Ganguly, is dedicated to creating groundbreaking treatments for various leg disorders. These disorders range from common conditions such as spider veins and varicose veins to more complex issues like diabetic foot and restless leg syndrome.
The company’s innovative approach utilizes advanced plant molecule technology to create a line of products that offer both topical and ingestible treatments, ensuring comprehensive care for sufferers of leg-related ailments.
The fresh injection of capital is earmarked for several strategic initiatives aimed at scaling the company’s operations. Key among these initiatives is the acquisition of top-notch talent to drive forward the company’s vision for innovative healthcare solutions. Additionally, Varco Leg Care plans to expand its retail presence, a move that will not only widen its market reach but also enhance the accessibility of its treatments to patients.
The company also plans to invest heavily in research and development (R&D) to further refine its product portfolio. By fostering a robust R&D culture, Varco Leg Care aims to stay at the cutting edge of leg health technology, ensuring that its treatments remain both effective and state-of-the-art.
Customer retention efforts are also set to receive a boost from the new funds. Varco Leg Care is committed to enhancing the patient experience and believes that a strong focus on customer satisfaction is key to maintaining and growing its customer base.
Despite the challenges of a competitive market, Varco Leg Care has already made impressive inroads, serving over 3 lakh customers and expanding its presence across 1,500 pharmacies in major Indian cities including Mumbai, Bengaluru, and Delhi. The company has also made its mark financially, with net revenue surpassing $1 million.
With its eyes set on a tenfold increase in monthly recurring revenue (MRR), Varco Leg Care is gearing up for aggressive growth. The company’s ambitious plans are a testament to its commitment to improving leg health and providing patients with the best possible care.
As Varco Leg Care continues to expand its reach and develop its offerings, the health-tech industry watches with interest. This recent funding round not only represents a vote of confidence from the investment community but also signals a new era of innovation and growth for the leg care specialist.
